Embecta Corporation EMBC 深 滬
等待開盤 03-26 09:30:00 美东时间
9.00
-0.010
-0.11%
華盛通- 最 高9.175
- 今 開9.11
- 成交量 76.80万股
- 最 低 8.84
- 昨 收 9.01
- 總市值 5.33亿
- 52周最高 15.25
- 市盈率 靜 5.56
- 換手率 1.30%
- 52周最低 8.72
- 委 比 42.52%
- 總股本 5921.99万
- 歷史最高 34.54
- 量 比 0.69
- 振 幅 3.72%
- 歷史最低 8.72
- 每 手 1
- 風險率 1.73%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Embecta Agrees To Acquire Owen Mumford For £150M
Embecta Corp. ("Embecta") (NASDAQ:EMBC), a global leader in diabetes care technology, today announced that it has entered into a definitive agreement to acquire Owen Mumford Holdings Limited ("Owen Mumford"), a privately
03-19 18:33
Embecta agrees to acquire Owen Mumford in deal valued up to GBP 150 million
Embecta agrees to acquire Owen Mumford in deal valued up to GBP 150 million Embecta agreed to acquire Owen Mumford for up to GBP 150 million, including GBP 100 million in upfront cash and up to GBP 50 million tied to Aidaptus auto-injector net sales over three years after closing. Closing is expecte
03-19 18:30
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers SCWorx (NASDAQ:WORX) stock moved upwards by 23.3% to $0.16 during Tues...
03-11 05:06
Embecta shareholders back board, pay, and equity plan
Embecta Corporation ( ($EMBC) ) has shared an announcement. At its Annual Meeti...
02-14 06:51
Embecta Corporation Held Annual Shareholder Meeting
Embecta Corporation Held Annual Shareholder Meeting Embecta Corporation held its Annual Meeting of Stockholders on February 11, 2026. All nominees for the board of directors were elected. Stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm
02-14 06:25
美股大行评级 | 遭多家大行下调目标价！亚马逊、Affirm、Roblox、汤森路透、Doximity、OneMain、Atlassian、Peloton等等
今日重点评级关注：HC Wainwright & Co.：维持NovaBridge Biosciences"买入"评级，目标价从7美元升至9美元；Truist Securities：维持Reddit"买入"评级，目标价从270美元升至275美元
02-09 14:37
Embecta Earnings Call: U.S. Headwinds, Global Offsets
Embecta Corporation (($EMBC)) has held its Q1 earnings call. Read on for the ma...
02-08 08:11
BTIG Reiterates Buy on Embecta, Maintains $25 Price Target
BTIG analyst Marie Thibault reiterates Embecta (NASDAQ:EMBC) with a Buy and maintains $25 price target.
02-06 18:30
Embecta meldet Forschungs- und Entwicklungsausgaben im ersten Quartal 2026 von 4,6 Mio. USD, ein Rückgang um 77 Prozent
Embecta meldet Forschungs- und Entwicklungsausgaben im ersten Quartal 2026 von 4,6 Mio. USD, ein Rückgang um 77 Prozent Embecta Corp. hat die Finanzergebnisse für das erste Quartal des Geschäftsjahres 2026 veröffentlicht. Der Umsatz belief sich im Berichtszeitraum auf 261,2 Mio. USD. Das Bruttoergeb
02-05 19:55
Embecta posts Q1 net income of USD 44.1 million
Embecta posts Q1 net income of USD 44.1 million Embecta Corporation (Nasdaq: EMBC) reported its financial results for the first quarter (Q1) of fiscal year 2026, covering the three months ended December 31, 2025. The company posted revenues of USD 261.2 million for the period. Gross profit for the q
02-05 19:55
